Delivery Order SPE2DB20D1100-SPE2DB25FE4B9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% DROP 10ML pharmaceutical product, with a completion date of April 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively competed. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,894.32 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of XDEMVY 0.25% Drop in 10ml quantities. This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency (DLA) for 0.25% XDEMVY drop in a 10 milliliter formulation, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency on August 14, 2025, with an ultimate completion date of September 5, 2025. The delivery order is for XDEMVY 0.25% Drop 10ML and utilizes firm fixed price pricing with no set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract was competitively awarded without a set-aside designation under firm fixed-price terms, with an ultimate completion date of June 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for pharmaceutical supplies valued at $1,223.59. The contract covers XDEMVY 0.25% DROP 10ML, a specialized pharmaceutical product, with an ultimate completion date of August 27, 2025. The award was made through a competitive process with no set-aside designation and utilizes firm fixed pricing. This delivery order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $1,223.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4B9Delivery Order
The Defense Logistics Agency awarded a $3,670.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml format, with an ultimate completion date of September 23, 2025. This non-set-aside award was made competitively and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical pharmaceutical distribution partner for federal medical procurement. This delivery order falls within AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen maintains an extensive portfolio of federal contract awards supplying a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill competitive federal procurements across multiple therapeutic domains and transaction values positions it as a major vendor within DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/2/25 |